For research purposes only. This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Research Use Only
PeptidesEarn 148 points with a free account
GLP-3 RT
A 39-amino acid triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, studied for metabolic regulation and body composition in clinical research. Premium Research Peptide.
$59.49
Bundle & Save
Discount applies automatically at checkout once your cart subtotal hits the tier.
Add $90.51 more to save 8% off
Fast delivery
Secure checkout
Overnight shipping available
We acceptVisaDiscoverAmexZelleCashApp
Product Details
Specifications
| Property | Details |
|---|---|
| Form | Lyophilized powder |
| Vial Size | 10mg, 20mg |
| Storage | Store in a cool, dry place away from direct light |
| Intended Use | This product is intended strictly for qualified laboratory researchers. It is not for human or veterinary consumption and must not be used as a drug, food additive, cosmetic, or household item. |
⚠️ Disclaimer: This compound is sold for in vitro research and educational purposes only. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. All buyers must be authorized research personnel or institutions.
Terms of Sale: By purchasing this product, you confirm that you are a qualified professional conducting lawful scientific research. Midwest Peptide and its affiliates are not liable for any misuse or mishandling of this material.
Frequently Asked Questions
What is GLP-3 RT?
+
GLP-3 RT is a research peptide also known as retatrutide, a synthetic 39-amino-acid triple agonist that activates the GLP-1, GIP, and glucagon receptors. It is the most-recently developed molecule in the GLP receptor agonist class and is supplied strictly for Research Use Only.
Is GLP-3 RT the same as retatrutide?
+
Yes. GLP-3 RT and retatrutide refer to the same molecule. GLP-3 indicates its position in the receptor agonist class (single GLP-1, dual GLP-1/GIP, triple GLP-1/GIP/glucagon), and retatrutide is the international nonproprietary name. Both names map to the identical sequence.
How does GLP-3 RT differ from GLP-2 TZ (tirzepatide)?
+
GLP-3 RT activates three receptors (GLP-1, GIP, glucagon) while GLP-2 TZ activates two (GLP-1, GIP). The added glucagon-receptor activity of GLP-3 RT is associated in research with stronger effects on energy expenditure, hepatic lipid handling, and metabolic rate.
What is GLP-3 RT used for in research?
+
Related Products
Other research peptides in this category
Learn More About GLP-3 RT
Research articles and insights related to GLP-3 RT
Why Is GLP-3 RT Better in Research Models?
Why GLP-3 RT outperforms single and dual incretin agonists in preclinical research models comes down to the glucagon receptor component, energy expenditure, and integrated metabolic axis engagement.
May 5, 2026
GLP-2 TZ vs GLP-3 RT: Which Is Better in Research?
GLP-2 TZ and GLP-3 RT differ in receptor count and downstream pharmacology. This research-context comparison covers mechanism, body composition, and how to choose between them.
May 5, 2026
Can I Buy GLP-3 RT?
Researchers can buy GLP-3 RT through the Research Use Only research peptide market. The molecule is not FDA approved, but RUO suppliers ship batch-verified material for laboratory work.
May 5, 2026
How Are People Getting GLP-3 RT?
GLP-3 RT is still in clinical development. The way researchers obtain GLP-3 RT for preclinical work is the Research Use Only supply chain, where COA-verified material is sold for laboratory studies.
May 5, 2026
1 / 4
Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
